India's Pharmaceutical Exports

Country Profile

Tajikistan

Tajikistan is an emerging destination for Indian pharmaceutical exports — $37.7M in FY 2025–26, with 2.7× growth over the past decade. Medicines accounts for 88% of shipments, with vaccines contributing $3.01M. The compound annual growth rate since FY2015 stands at 9.3%.

🇹🇯 $37.7M · 2.7× growth since FY2015 · 9.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$37.7M
Exports FY2025–26 DGCIS
2.7×
Growth FY2015→2026
9.3%
CAGR FY2015→2026
88%
Medicines Share
5
Product Categories Supplied
Tajikistan is an emerging destination for Indian pharmaceutical exports — $37.7M in FY 2025–26, with 2.7× growth over the past decade. Medicines accounts for 88% of shipments, with vaccines contributing $3.01M. The compound annual growth rate since FY2015 stands at 9.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $33.0M (87.5%) Vaccines $3.01M (8.0%) Traditional & Herbal $965K (2.6%) Surgical & Hospital Supplies $661K (1.8%) Medicine Ingredients $60K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Tajikistan in the RBI overseas direct investment dataset (2011–2026).